Roke Biotechnologies Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
3
Roke Biotechnologies General Information
Description
Developer of a protein manufacturing platform designed for biomanufacturing applications. The company's platform integrates genomic design, strain optimization, and high-throughput screening capabilities, enabling industrial biotechnology companies to accelerate microbial strain development, reduce research and development timelines, and improve yield and scalability in commercial production processes through data-driven iteration and automation.
Contact Information
Website
www.rokebio.comCorporate Office
- 2530 Meridian Parkway, 300
- Durham, NC 27713
- United States
Corporate Office
- 2530 Meridian Parkway, 300
- Durham, NC 27713
- United States
Roke Biotechnologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Accelerator/Incubator | 01-Mar-2026 | Completed | Generating Revenue | |||
| 2. Grant | Completed | Generating Revenue | ||||
| 1. University Spin-Out | 01-Jan-2021 | Completed | Generating Revenue |
Roke Biotechnologies Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Christensen Family Center for Innovation | Accelerator/Incubator | |||
| Duke University | University | |||
| North Carolina Department of Commerce | Corporation |
Roke Biotechnologies FAQs
-
When was Roke Biotechnologies founded?
Roke Biotechnologies was founded in 2021.
-
Where is Roke Biotechnologies headquartered?
Roke Biotechnologies is headquartered in Durham, NC.
-
What industry is Roke Biotechnologies in?
Roke Biotechnologies’s primary industry is Laboratory Services (Healthcare).
-
Is Roke Biotechnologies a private or public company?
Roke Biotechnologies is a Private company.
-
What is Roke Biotechnologies’s current revenue?
The current revenue for Roke Biotechnologies is .
-
Who are Roke Biotechnologies’s investors?
Christensen Family Center for Innovation, Duke University, and North Carolina Department of Commerce have invested in Roke Biotechnologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process